期刊
DRUG DISCOVERY TODAY
卷 25, 期 7, 页码 1213-1222出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2020.04.024
关键词
-
资金
- National Centre for Research and Development, Warsaw, Poland [STRATEGMED3/306853]
Telomerase is a reverse transcriptase enzyme involved in DNA synthesis at the end of linear chromosomes. Unlike in most other cells, telomerase is reactivated most cancerous cells and, therefore, has become a promising new anticancer target. Despite extensive research, direct telomerase inhibitors have yet not been introduced to the clinics because of the complexity of this enzyme. Structures of this protein from simple organisms and human homology models are currently available and have been used in structure-based drug design efforts to find potential inhibitors. Different is silico strategies have been applied and different chemical groups have been explored. Here, we provide an overview of recent discoveries.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据